Precision BioSciences, Inc.
DTIL
$4.49
-$0.28-5.87%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/1/2025
-
Insider Monkey
4/1/2025
-
Insider Monkey
4/1/2025
-
GuruFocus
4/1/2025
-
Business Wire
3/31/2025
-
Insider Monkey
3/28/2025
-
Ticker Report
3/28/2025
-
MarketBeat
3/26/2025
-
GuruFocus
3/26/2025
-
Zacks Investment Research
3/26/2025
-
The Fly
3/26/2025
-
Business Wire
3/25/2025
-
SeekingAlpha.com: All News
3/21/2025
-
GuruFocus
3/21/2025
-
Business Wire
3/20/2025
-
GuruFocus
3/20/2025
-
Business Wire
3/19/2025
-
Zacks Investment Research
3/19/2025
-
The Fly
3/19/2025
-
Business Wire
3/17/2025
-
GuruFocus
3/17/2025
-
The Fly
3/17/2025
-
Business Wire
3/13/2025
-
Zolmax
2/24/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, March 26, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
919 314 5512
Address
302 East Pettigrew Street
Durham, NC 27701
Durham, NC 27701
Country
Year Founded
Business Description
Sector
Precision BioSciences, Inc., an advanced gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision in the United States...
more
